PANEL: Commercialisation Journeys – Strategic Alliances and Partnerships | Kisaco Research

Given the complexity and cost of the commercialisation journey, strategic alliances and partnerships become a key decision for all founders. This panel will discuss the who, the why, and perhaps most crucially the decision around when to partner.

  • Improving capital efficiency within the animal health market
  • Factors to consider when evaluating and planning route to market
  • How strategic partners will leverage data and AI to help guide start-ups and speed to commercialisation
  • Drivers of successful partnerships and the realisation of value
Speaker(s): 
Moderator

Author:

Rimma Driscoll

Executive Vice President and Head of Global Strategy, Commercial and Business Development
Zoetis

Rimma Driscoll is an executive in Global Business Development and Strategic Alliances with 20+ years in the field. Rimma has a depth of experience in a broad range of global transactions including JVs,Strategic Alliances, Collaborations, Acquisitions, Divestitures, Licensing Deals, and Partnerships. This experience span from small Discovery deals to multi-billionaire dollar divestitures. Rimma guides Multi-function teams on the external strategies and then leads all aspects of negotiations, and leverages external relationships to bring transactions to closure. She has worked extensively in Pharmaceuticals, Consumer Healthcare and Consumer Products businesses.

Rimma Driscoll

Executive Vice President and Head of Global Strategy, Commercial and Business Development
Zoetis

Rimma Driscoll is an executive in Global Business Development and Strategic Alliances with 20+ years in the field. Rimma has a depth of experience in a broad range of global transactions including JVs,Strategic Alliances, Collaborations, Acquisitions, Divestitures, Licensing Deals, and Partnerships. This experience span from small Discovery deals to multi-billionaire dollar divestitures. Rimma guides Multi-function teams on the external strategies and then leads all aspects of negotiations, and leverages external relationships to bring transactions to closure. She has worked extensively in Pharmaceuticals, Consumer Healthcare and Consumer Products businesses.

Panellists

Author:

Megan Grether

Head of Global Business Development and Licensing Animal Health
Boehringer Ingelheim

Megan Grether

Head of Global Business Development and Licensing Animal Health
Boehringer Ingelheim

Author:

Justine Conway

Vice President of Business Development & External Innovation
Elanco

Justine Conway

Vice President of Business Development & External Innovation
Elanco

Author:

Jim McIntyre

Head of Global Business Development
Merck Animal Health

Jim McIntyre

Head of Global Business Development
Merck Animal Health
Time: 
9:50am - 10:20am
Session Type: 
General Session (Presentation)